The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up. (Q53238572)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 June 2011

Language	Label	Description	Also known as
English	The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up.	scientific article published on 24 June 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

The value of echocardiography versus cardiac troponin I levels in the early detection of anthracycline cardiotoxicity in childhood acute leukemia: prospective evaluation of a 7-year-long clinical follow-up. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

echocardiography

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kazım Oztarhan

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Serhat Guler

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Belgin Aktas

3

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Meliha Arslan

4

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Zafer Salcioglu

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Gonul Aydogan

6

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

publication date

24 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Pediatric Hematology and Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

28

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

5

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

380-394

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Long-term survivors of childhood cancer. The medical consequences of cure

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Cardiac toxicity 4 to 20 years after completing anthracycline therapy

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Prevention of anthracycline-induced cardiotoxicity in children: the evidence

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Detection of anthracycline-induced cardiotoxicity.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury.

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Exercise radionuclide ventriculography in children: normal values for exercise variables and right and left ventricular function

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Causes of childhood leukaemia and lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Comparison of peak exercise oxygen uptake in men versus women in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Risk factors for doxorubicin-induced congestive heart failure

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Doxorubicin Cardiomyopathy: Evaluation by Phonocardiography, Endomyocardial Biopsy, and Cardiac Catheterization

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.563772

21 January 2018

Identifiers

10.3109/08880018.2011.563772

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/21699467

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53238572&oldid=1531573635"